The results were presented, in part, at the Activities and Co-operation for Drug Safety in Asia joint meeting, Tokyo, Japan, October 29–31, 2010.
Original Research Articles
Development and Validation of a Pharmacy-Based Comorbidity Measure in a Population-Based Automated Health Care Database
Article first published online: 5 FEB 2013
© 2013 Pharmacotherapy Publications, Inc.
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Volume 33, Issue 2, pages 126–136, February 2013
How to Cite
- Issue published online: 5 FEB 2013
- Article first published online: 5 FEB 2013
- Manuscript Accepted: 27 JUN 2012
- Manuscript Received: 12 MAR 2012
- Department of Health. Grant Number: DOH098-TD-D-113-098016
Appendix S1. Comparison Between Disease Categories of the Chronic Disease Score (CDS) and Drug Categories of the Pharmacy-Based Disease Indicator (PBDI), with Regression Coefficients, Odds Ratios, and Proportion of Individuals for the 37 PBDI Drug Categories.
Appendix S2. Regression Coefficients and Odds Ratios for the Pharmacy-Based Disease Indicator (PBDI), the Deyo Version of Charlson Index, Age Group, and Sex in Relation to Subsequent-year Hospitalization.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.